Suppr超能文献

根据任何癌症的家族史,上皮性卵巢癌的发病率和死亡率。

Incidence and mortality in epithelial ovarian cancer by family history of any cancer.

机构信息

Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany.

出版信息

Cancer. 2011 Sep 1;117(17):3972-80. doi: 10.1002/cncr.26016. Epub 2011 Mar 1.

Abstract

BACKGROUND

Practically all data on familial risk in ovarian and other cancers are based on incident cancer, whereas familiality in cancer mortality is largely unknown. If fatal forms of cancer are a highly familial subtype, then familial risk for mortality may exceed that of incidence, which is relevant for clinical decision making and counseling.

METHODS

Ovarian cancer patients in the nationwide Swedish Family Cancer Database were classified according to fatal and nonfatal (incident) family history. Familial risks for incident and fatal ovarian cancer were calculated for offspring based on their parental or sibling family history of any cancer using standardized incidence ratios (SIRs) for incidence and standardized mortality ratios (SMRs) for mortality. Offspring without family history were referents.

RESULTS

The database included 24,757 mothers and 8138 daughters with ovarian cancer. When a mother had ovarian cancer, the SIR for incident ovarian cancer in daughters was 2.69, and when a sister had ovarian cancer it was 3.49. The SMRs for fatal cancer by fatal cancer in probands were 3.39 and 5.80, respectively. For fatal serous cancers among siblings, the SMR was 6.16, compared with 10.01 for the endometrioid type. Ovarian cancer was associated with maternal (SIR, 1.22; SMR, 1.56) and sororal breast cancer (SIR, 1.27). Another discordant association was between ovarian and paternal prostate cancer (SIR, 1.12; SMR, 1.66).

CONCLUSIONS

Fatal familial risks were higher for concordant ovarian, ovarian-breast, and ovarian-prostate cancers than the corresponding incident risks. This may suggest that highly fatal subtypes exist for these cancers, calling for genetic dissection.

摘要

背景

实际上,所有关于卵巢癌和其他癌症家族风险的资料都基于发病癌症,而癌症死亡率的家族性则知之甚少。如果致命形式的癌症是一种高度家族性亚型,那么死亡率的家族风险可能超过发病风险,这与临床决策和咨询有关。

方法

根据致命和非致命(发病)家族史,将全国性瑞典家族癌症数据库中的卵巢癌患者进行分类。根据父母或兄弟姐妹的任何癌症家族史,为后代计算发病和致命卵巢癌的家族风险,使用发病的标准化发病比(SIR)和死亡率的标准化死亡率比(SMR)。没有家族史的后代为参照。

结果

该数据库包括 24757 名患有卵巢癌的母亲和 8138 名患有卵巢癌的女儿。当母亲患有卵巢癌时,女儿发病卵巢癌的 SIR 为 2.69,当姐妹患有卵巢癌时,SIR 为 3.49。根据先证者致命癌症的 SMRs 分别为 3.39 和 5.80。对于兄弟姐妹中的致命浆液性癌症,SMR 为 6.16,而子宫内膜样癌症为 10.01。卵巢癌与母亲(SIR,1.22;SMR,1.56)和姐妹乳腺癌(SIR,1.27)有关。另一个不一致的关联是卵巢癌与父系前列腺癌(SIR,1.12;SMR,1.66)之间。

结论

与相应的发病风险相比,一致性卵巢癌、卵巢-乳腺癌和卵巢-前列腺癌的致命家族风险更高。这可能表明这些癌症存在高度致命的亚型,需要进行基因分析。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验